Development of Novel Cholecystokinin 2 Receptor-Targeted Radioligand Containing Albumin Binder for Efficient <sup>111</sup> In/ <sup>177</sup> Lu Theranostics

Authors

Institutions

Publication Details

Journal
Bioconjugate Chemistry
Published
2026-06-12
DOI
https://doi.org/10.1021/acs.bioconjchem.6c00272
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of Novel Cholecystokinin 2 Receptor-Targeted Radioligand Containing Albumin Binder for Efficient 111 In/ 177 Lu Theranostics

Kazuma Nakashima, Masahiro Ono, Hiroyuki Watanabe, Takahiro Yamamoto et al.
Bioconjugate Chemistry
Radiopharmaceutical Chemistry and Applications
article

Development of Novel Cholecystokinin 2 Receptor-Targeted Radioligand Containing Albumin Binder for Efficient 111 In/ 177 Lu Theranostics

Kazuma Nakashima, Masahiro Ono, Hiroyuki Watanabe, Takahiro Yamamoto, Nobuki Kazuta
article en

Abstract

No abstract available for this paper.
Bioconjugate Chemistry
Kyoto University (JP)
Good health and well-being
Openalex Percentile: Top 6%
Radiopharmaceutical Chemistry and Applications
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development of Novel Cholecystokinin 2 Receptor-Targeted Radioligand Containing Albumin Binder for Efficient <sup>111</sup> In/ <sup>177</sup> Lu Theranostics — Kazuma Nakashima, Masahiro Ono, et al. · Bioconjugate Chemistry (2026) | TGRS Research Map | TGRS